Direxion Nanotechnology ETF
TYNE
TYNE was delisted on the 17th of February, 2023.
0 hedge funds and large institutions have $0 invested in Direxion Nanotechnology ETF in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $383K → $0 (-$383K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$383K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citigroup
New York
| – | -$383K | -23,073 | Closed |
|
TYNE Hedge Fund Activity: Q1 2023 in Review
0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Direxion Nanotechnology ETF (TYNE) for Q1 2023, worth a combined $0 — down 100% from $383K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TYNE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Citigroup, exiting entirely with an estimated $383K sold.
- 0 institutional investors held Direxion Nanotechnology ETF (TYNE) as of Q1 2023, down from 1 in Q4 2022.
- Funds reported $0 of Direxion Nanotechnology ETF stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Direxion Nanotechnology ETF positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest Direxion Nanotechnology ETF seller in Q1 2023 was Citigroup, an estimated $383K sold.
Based on aggregated 13F filings for Q1 2023.